Antagonism of kinin effects on epithelial by Hoe 140: apparently competitive and non-competitive interactions.
1. Hoe-140, a potent kinin receptor antagonist, was investigated for its ability to inhibit the effects of lysylbradykinin (kallidin) on a cultured colonic epithelium, HCA-7 Colony 29, derived from a human adenocarcinoma. 2. Measurements of electrogenic chloride secretion (as short circuit current), and of intracellular Ca2+ (from Fura-2 fluorescence) were used to assess the action of lysylbradykinin in the absence and presence of Hoe 140. 3. From short circuit current data, Hoe 140 appeared to be a competitive antagonist with a Ki value of 5 nM. However, with measurements of intracellular Ca2+ Hoe 140 was apparently a non-competitive antagonist with a Ki of between 4-6 nM. 4. Because of the unexpected finding of non-competitive antagonism, measurements were made with a second antagonist pair, histamine and mepyramine. Mepyramine behaved as a competitive antagonist against responses to histamine with a Ki value of approximately 5 nM when short circuit current measurements were evaluated. However, when intracellular Ca2+ concentration was used as a measure mepyramine, 30 nM, produced a near parallel shift in the response curve, but at 100 nM the maximal response was depressed. 5. The reasons why the apparent type of antagonism depends upon the method of measurement is discussed, bearing in mind that the increase in intracellular Ca2+ is a signal which precedes the increase in short circuit current.
D000230:Adenocarcinoma / Q000378:metabolism; D001667:Binding, Competitive / Q000187:drug effects; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism; D003110:Colonic Neoplasms / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects; D016257:Fura-2; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D007609:Kallidin / Q000494:pharmacology; D007705:Kinins / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000378:metabolism
D002712:Chlorides; D007473:Ion Channels; D007705:Kinins; D007609:Kallidin; C065679:icatibant; D006632:Histamine; D011738:Pyrilamine; D001920:Bradykinin; D002118:Calcium; D016257:Fura-2